Pathstone Holdings
IBB icon

Pathstone Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Pathstone Holdings’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
8,071
+1,834
+29% +$315K ﹤0.01% 1273
2026
Q1 		$1.05M Buy
6,237
+1
+0% +$171 ﹤0.01% 1382
2025
Q4 		$1.05M Buy
6,236
+3
+0% +$487 ﹤0.01% 1379
2025
Q3 		$900K Sell
6,233
-1,201
-16% -$164K ﹤0.01% 1486
2025
Q2 		$940K Sell
7,434
-179
-2% -$22K ﹤0.01% 1425
2025
Q1 		$974K Buy
7,613
+727
+11% +$98.6K ﹤0.01% 1397
2024
Q4 		$912K Buy
6,886
+120
+2% +$16.9K ﹤0.01% 1414
2024
Q3 		$985K Sell
6,766
-246
-4% -$35.6K ﹤0.01% 1376
2024
Q2 		$962K Sell
7,012
-1,641
-19% -$219K ﹤0.01% 1353
2024
Q1 		$1.19M Buy
8,653
+353
+4% +$48.2K 0.01% 1179
2023
Q4 		$1.13M Buy
+8,300
New +$1.01M 0.01% 1016

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Pathstone Holdings's IBB Position: Q2 2026 in Review

Pathstone Holdings increased its iShares Biotechnology ETF (IBB) stake by 29% in Q2 2026, buying an estimated $315K and bringing the position to 8,071 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Pathstone Holdings first reported a position in IBB in Q4 2023 and has held it in 11 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Pathstone Holdings held 8,071 shares of iShares Biotechnology ETF worth $1.53M as of Q2 2026.
  • Pathstone Holdings bought 1,834 iShares Biotechnology ETF shares in Q2 2026, an estimated $315K.
  • iShares Biotechnology ETF made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1273 holding.
  • Pathstone Holdings first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.